Suita, Japan

Hideki Yoshikawa

This inventor holds 10 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Osaka University, Nippon Zoki Pharmaceutical Co., Ltd., National Institute for Materials Science. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideki Yoshikawa. Retrieved from https://idiyas.com/inventor/hideki-yoshikawa-zkoh60fz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10 

% Patents Active = 80.0

 

 

Average Co-Inventor Count = 5.3

ph-index = 1


Location History:

  • Tsukuba, JP (2013 - 2016)
  • Suita, JP (2021 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Inventor Hideki Yoshikawa

Introduction: Hideki Yoshikawa is a renowned inventor based in Suita, Japan, known for his groundbreaking contributions to various technological fields.

Latest Patents: Hideki Yoshikawa holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies.

Career Highlights: With a career spanning over two decades, Hideki Yoshikawa has worked with leading research institutions and universities to develop innovative solutions for complex challenges in the tech industry.

Collaborations: Throughout his career, Hideki Yoshikawa has collaborated with top companies, such as Sony and Toyota, to bring his inventions to the market and make a significant impact on the industry.

Conclusion: Hideki Yoshikawa's dedication to innovation and his passion for pushing the boundaries of technology have solidified his reputation as a pioneering inventor in Japan and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…